Panagora Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-465
Closed -$28K 2873
2020
Q3
$28K Sell
465
-3,244
-87% -$195K ﹤0.01% 2130
2020
Q2
$259K Buy
3,709
+465
+14% +$32.5K ﹤0.01% 1439
2020
Q1
$146K Sell
3,244
-11,760
-78% -$529K ﹤0.01% 1557
2019
Q4
$976K Sell
15,004
-22,559
-60% -$1.47M ﹤0.01% 1063
2019
Q3
$2.33M Sell
37,563
-13,996
-27% -$869K 0.01% 684
2019
Q2
$3.67M Sell
51,559
-184,024
-78% -$13.1M 0.02% 594
2019
Q1
$18.5M Buy
235,583
+36,058
+18% +$2.83M 0.08% 244
2018
Q4
$16.9M Buy
199,525
+716
+0.4% +$60.6K 0.08% 230
2018
Q3
$34M Sell
198,809
-6,474
-3% -$1.11M 0.13% 164
2018
Q2
$26.5M Buy
205,283
+8,314
+4% +$1.07M 0.11% 190
2018
Q1
$20.3M Buy
196,969
+698
+0.4% +$71.9K 0.08% 222
2017
Q4
$16.8M Sell
196,271
-9,690
-5% -$828K 0.06% 277
2017
Q3
$17.5M Sell
205,961
-3,112
-1% -$264K 0.07% 273
2017
Q2
$15.8M Sell
209,073
-104
-0% -$7.88K 0.06% 296
2017
Q1
$13.8M Sell
209,177
-19,670
-9% -$1.3M 0.06% 333
2016
Q4
$14.5M Sell
228,847
-725
-0.3% -$46K 0.07% 297
2016
Q3
$14.6M Sell
229,572
-71,018
-24% -$4.52M 0.07% 278
2016
Q2
$22.4M Sell
300,590
-15,635
-5% -$1.16M 0.11% 187
2016
Q1
$21.1M Sell
316,225
-2,126
-0.7% -$142K 0.1% 205
2015
Q4
$21.5M Buy
318,351
+11,647
+4% +$788K 0.11% 202
2015
Q3
$16.4M Buy
306,704
+35,598
+13% +$1.9M 0.09% 248
2015
Q2
$17.1M Sell
271,106
-5,339
-2% -$336K 0.09% 252
2015
Q1
$13.3M Buy
276,445
+20,003
+8% +$962K 0.07% 285
2014
Q4
$8.51M Buy
256,442
+10,061
+4% +$334K 0.04% 356
2014
Q3
$7.22M Sell
246,381
-110,032
-31% -$3.23M 0.04% 399
2014
Q2
$13.9M Sell
356,413
-79,879
-18% -$3.1M 0.07% 273
2014
Q1
$18.3M Buy
436,292
+41,262
+10% +$1.73M 0.09% 230
2013
Q4
$13M Buy
395,030
+117,395
+42% +$3.85M 0.06% 303
2013
Q3
$7.5M Sell
277,635
-18,455
-6% -$498K 0.04% 408
2013
Q2
$6.91M Buy
+296,090
New +$6.91M 0.04% 378